Skip to content
Review Open access

Real-World Outcomes of a Pediatric Kidney Genetics Clinic: Diagnostic Yield, Variants of Uncertain Significance, and Clinical Translation.

Aug 2026 · Kidney360 · 0 citations
Medicine

TL;DR

By integrating genetic testing, expert variant interpretation, and clinical translation, this multidisciplinary model addresses key barriers in pediatric kidney genetics and supports broader adoption of kidney genetics clinics to optimize genomic evaluation and care for children with kidney disease.

Abstract

Background

Despite the growing role of genetic testing in pediatric kidney disease, translating genomic findings into clinical care remains challenging due to limited kidney genetics expertise and infrastructure. Specialized kidney genetics clinics may optimize both testing strategies and clinical application, though outcomes remain underreported.

Methods

We performed a retrospective analysis of the first two years (11/2022 - 11/2024) of the Boston Children's Hospital kidney genetics clinic, led by two pediatric nephrologists with genetics expertise and a certified genetic counselor. Our referral model, services, outcomes, clinical impacts, and considerations for genetic testing are reviewed.

Results

One-hundred and four individuals were referred to our clinic. Indications for referral included pre-test counseling and genetic testing implementation (64/104), counseling or clinical evaluation for externally ordered test results (38/104), and clinical confirmation of research-based results (2/104). Of 64 probands referred for pre-test counseling, we recommended genetic testing for 58% of individuals (37/64) and identified a diagnostic variant in 51% of those tested (19/37). Across all 104 probands, 77 underwent genetic testing, either by our clinic or external providers. The cohort showed substantial genetic heterogeneity; 46 individuals had kidney genetic diagnoses across 28 genes. Forty-seven individuals carried at least one variant of uncertain significance (VUS), seven (15%) of which were considered diagnostic after adjudication. Ten additional candidate variants and incidental findings were detected. Overall, 68% of tested patients had at least one physician-reported clinical impact, including diagnostic certainty (43/77, 56%), change in disease management (49/77, 64%), and family planning implications (20/77, 26%).

Conclusions

A specialized pediatric kidney genetics clinic achieves high diagnostic yield and demonstrates measurable clinical impact. By integrating genetic testing, expert variant interpretation, and clinical translation, this multidisciplinary model addresses key barriers in pediatric kidney genetics and supports broader adoption of kidney genetics clinics to optimize genomic evaluation and care for children with kidney disease.

Read PDF

Similar papers

Review Open access Oct 2026

Genetic Testing in Pediatric Cardiomyopathies: Diagnostic Yield, Variants of Uncertain Significance and Implications for Genetic Counseling

Current evidence from test selection to genetic counseling, management of relatives when only a variant of uncertain significance is identified, surveillance of genotype-positive, phenotype-negative relatives, psychosocial impact and shared responsibility for recontact after reclassification are summarized.

Iuliana Maria Zaharia, S. A. Rițiu, Norbert Wellmann et al. · 0 citations
Review Open access Oct 2026

The Value of Integrating Adult Genetic Services Into Pregnancy Care: Changing Fetal, Neonatal, and Maternal Management.

Adult patients with known or suspected genetic diagnoses face unique challenges in accessing care that informs pregnancy management and reproductive decision-making. To address this gap, we established an Adult Genetics & Reproductive Health Clinic (AGRH). We conducted a retrospective study of 112 patients evaluated be...

Madeline J. Dyke, E. Hardisty, N. Vora et al. · 0 citations
Open access Oct 2026

Diagnostic Yield, Diagnostic Delay, and Clinical Utility of Genetic Testing in 930 Children with Suspected Genetic Epilepsy

Background: Next-generation sequencing (NGS) has transformed pediatric epilepsy care, but real-world data on diagnostic delay and clinical utility remain limited, particularly in Chinese populations. Methods: This retrospective cohort included 930 children with suspected genetic epilepsy. Diagnostic delay was defined a...

Rui Dong, Hong-Wei Zhang, Xiao-Chen Wang et al. · 0 citations
Open access Oct 2026

10 tips to integrate genetic testing into nephrology practice

A substantial subset of chronic kidney disease has an underlying monogenic cause, both in children and adults. Modern sequencing technologies provide the means for broad genetic testing. Approaches to therapy and patient care become increasingly aetiology-based. Thus, unravelling the genetic cause is getting clinical...

Carsten Bergmann, Ines Schmidts, N. Bachmann · 0 citations
Open access Sep 2026

Interdisciplinary management and genetic evaluation of pediatric cancer predisposition syndromes: a retrospective cohort study.

The interdisciplinary CPS consultation model contributes to identifying hereditary cancer predisposition in pediatric patients and families and provides a scalable foundation for systematic CPS assessment and development of standardized, evidence-based surveillance protocols in pediatric oncology.

N. Dikow, Anna-Katharina Nitschke, S. Hirsch et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.